Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Comparative toxicity of diuron on survival and growth of Pacific treefrog, bullfrog, red-legged frog, and African clawed frog embryos and tadpoles.

The effects of the herbicide diuron on survival and growth of Pacific treefrog (Pseudacris regilla), bullfrog (Rana catesbeiana), red-legged frog (Rana aurora), and African clawed frog (Xenopus laevis) embryos and tadpoles were determined in static-renewal tests. P. regilla and X. laevis embryos had reduced growth and developed increased deformities in diuron concentrations over 20 mg/L. Hindlimb bud and forelimb development were retarded in R. aurora following 14 days exposure to diuron concentrations of > 7.6 mg/L. Mean 14-day LC50s for P. regilla and X. laevis tadpoles were 15.2 and 11.3 mg/L diuron, respectively. The 21-day LC50 for R. catesbeiana tadpoles was 12.7 mg/L diuron. The 14-day LC50 for R. aurora tadpoles was 22.2 mg/L. The lowest NOAELs calculated in embryo tests were 14.5 mg/L for P. regilla (10 days) and 7.6 mg/L diuron for X. laevis (4 days). The lowest NOAELs calculated in tadpole tests were: P. regilla, 14.5 mg/L (14 days); R. catesbeiana, 7.6 mg/L (21 days); R. aurora, 7.6 mg/L (14 days); and X. laevis, > 29.1 mg/L (14 days). Diuron concentrations having an effect on survival, growth, and malformation in the laboratory were much higher than those found in normal field spray situations; field studies would be needed to determine the hazard to amphibians in areas of localized pooling of recently applied herbicide in the environment.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app